Table 4.
Systemic parameters at baseline and after 6 and 12 months treatment of Group 1- Periodontitis (mean ± SD).
| parameter | Before | After treatment | ||||
|---|---|---|---|---|---|---|
| Baseline n = 24 | 6 months n = 24 | p-value baseline to 6 months | 12 months n = 24 | p-value 6 to 12 months | p-value baseline to 12 months | |
| Glucose (mg/dL) | 157.7 ± 37.5 | 182.6 ± 71.4 | 0.032 | 168.1 ± 48.2 | n.s. | n.s. |
| A1c (%) | 9.4 ± 1.7 | 8.7 ± 1.5 | 0.006 | 8.9 ± 1.6 | n.s. | n.s. |
| hs-CRP (mg/L)a | 3.4 ± 4.9 | 2.2 ± 4.6 | n.s. | 1.9 ± 3.5 | n.s. | 0.041 |
| Ox-LDL (unit) | 1.66 ± 0.60 | 1.69 ± 0.59 | n.s. | 1.70 ± 0.55 | n.s. | n.s. |
| Total Cholestrol (mg/dL) | 219.7 ± 34.5 | 220.0 ± 40.0 | n.s. | 217.2 ± 24.5 | n.s. | n.s. |
| HDL-c (mg/dL) | 64.0 ± 18.2 | 58.5 ± 17.1 | n.s. | 56.9 ± 15.1 | n.s. | n.s. |
| LDL-c (mg/dL) | 114.8 ± 41.7 | 118.1 ± 41.9 | n.s. | 125.0 ± 31.0 | n.s. | n.s. |
| TG (mg/dL) | 204.2 ± 64.5 | 216.3 ± 70.3 | n.s. | 175.9 ± 35.2 | n.s. | n.s. |
| Phase shift: θ | 0.10 ± 0.05 | 0.13 ± 0.06 | n.s. | 0.16 ± 0.07 | n.s. | 0.025 |
| K (W/m.K) | 0.52 ± 0.22 | 0.38 ± 0.07 | 0.004 | 0.40 ± 0.08 | n.s. | 0.035 |
| Abs (λ = 480 nm)b | 0.63 ± 0.23 | 0.75 ± 0.30 | n.s. | 0.93 ± 0.33 | n.s. | 0.002 |
aParameter not normally distributed, expressed as median and interquartile range, Friedman ANOVA. bAbs is LDL-c solution absorbance that is proportional to the sample absorption coefficient α. n.s—not significant. Values in bold show statistically significant difference (p < 0.05). ANOVA One-way repeated Measures/Tukey Test.